Clinical Research
Currently recruiting studies
We have a number of projects that are currently looking for volunteers to take part. These include clinical trials and non-interventional studies. You can view these by clicking the link below.
If there is nothing suitable for you at the moment then please do sign up for our contact database so we can get in touch with you about any future opportunities.
Examples of our other clinical research
Neuro-GD study: Comparing genetic developmental conditions
The aim of this study is to understand how similar fragile X syndrome and SYNGAP1 related intellectual disabilities are. Background
EVOSIS – Sleep in SYNGAP1
The aim of this research is to study sleep and sleep-wake cycle in SYNGAP1-related Intellectual Disability. The study will
Longitudinal study of adolescents with additional support needs
Background An intellectual disability is due to a difference in brain development, either before birth or in early childhood. People
Imaging Fragile X
Background Fragile X syndrome is the most common monogenic (meaning linked to a single gene) cause of intellectual and developmental
Is it helpful to teach social skills to autistic adults?
Background Autistic people often experience difficulties with social communication, which can have negative consequences for their overall quality of life.
Age related brain changes in FMR1 premutation carriers
Why did we do this study? People with the genetic FMR1 premutation may develop in later life a condition called
A working memory intervention for fragile X syndrome
Background People with fragile X syndrome experience different strengths and weaknesses than neurotypical people. One of these differences is in
Comparing the autism and schizophrenia spectrums
Background Although widely regarded as separate conditions, there are clear overlaps between some of the difficulties experienced by people with
Health of female FMR1 premutation carriers
Background The FMR1 (fragile X messenger ribonucleoprotein 1) gene exists in different forms, some longer than the typical short version.
Novartis AFQ056 trials in fragile X syndrome
Background Fragile X syndrome is the most common monogenic (meaning linked to a single gene) cause of intellectual and developmental
